MODD · Modular Medical, Inc.

Modular Medical, Inc. executed a significant corporate restructuring through a 1-for-30 reverse stock split, effective March 31, 2026. The action was undertaken to regain compliance with Nasdaq's $1.00 minimum bid price listing requirement. The Certificate of Amendment was filed with the Nevada Secretary of State on March 30, 2026, following shareholder approval at the fiscal 2026 Annual Meeting on January 23, 2026, where 65.14% of voting power approved the measure. The reverse split reduces the outstanding common stock from 139,810,797 shares to approximately 4,660,360 shares. The number of authorized shares and the par value of $0.001 per share remain unchanged. All equity awards, reserved shares, and outstanding warrants are subject to proportionate adjustment, with share counts divided by 30 and exercise prices multiplied by 30. Holders of fractional shares will receive cash in lieu of shares. The Company's common stock began trading on a split-adjusted basis under the new CUSIP number 60785L306 on March 31, 2026. Colonial Stock Transfer Co., Inc. is acting as the exchange agent for the transaction.